Invesco Ltd. Acelrx Pharmaceuticals Inc Transaction History

Invesco Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$1.03 - $1.7 $26,015 - $42,938	-25,258 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.25 - $2.77 $7,940 - $17,595	6,352 Added 33.6%	25,258 $43,000
Q4 2020 Feb 16, 2021	BUY	$1.18 - $1.98 $22,309 - $37,433	18,906 New	18,906 $23,000
Q1 2019 May 15, 2019	SELL	$2.35 - $3.83 $39,158 - $63,819	-16,663 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.13 - $4.8 $35,492 - $79,982	16,663 New	16,663 $38,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.